Table 3.
Model | HbA1c parameter | R | R2 | Adj R2 | Standardize β | B (95% CI) | p value |
---|---|---|---|---|---|---|---|
Unadjusted | eAG-30 | 0.83 | 0.689 | 0.69 | 0.83 | 0.97 (0.79–1.16) | < 0.001 |
eAG-90 | 0.81 | 0.656 | 0.65 | 0.81 | 0.99 (0.79–1.21) | < 0.001 | |
POCT-HbA1c | 0.83 | 0.689 | 0.72 | 0.85 | 0.94 (0.77–1.11) | < 0.001 | |
Adjusted Module 1 | eAG-30 | 0.84 | 0.706 | 0.68 | 0.83 | 0.98 (0.76–1.17) | < 0.001 |
eAG-90 | 0.81 | 0.656 | 0.64 | 0.81 | 0.99 (0.78–1.19) | < 0.001 | |
POCT-HbA1c | 0.86 | 0.740 | 0.72 | 0.86 | 0.95 (0.77–1.12) | < 0.001 | |
Adjusted Module 2 | eAG-30 | 0.84 | 0.706 | 0.67 | 0.98 | 0.98 (0.78–1.17) | < 0.001 |
eAG-90 | 0.81 | 0.656 | 0.63 | 0.81 | 0.99 (0.77–1.20) | < 0.001 | |
POCT-HbA1c | 0.87 | 0.757 | 0.73 | 0.87 | 0.96 (0.79–1.13) | < 0.001 |
Dependent variable is laboratory HbA1c, and independent variables are eAG-30, eAG-90, and POCT- HbA1c
Module 1 was adjusted for age and gender, and module 2 was adjusted for all variables in Model 1 plus duration of DM, type of diabetes, and treatment